Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.

ABSTRACT:

Background

Pharmacogenetic testing (PGx) has the potential to improve the quality of psychiatric prescribing by considering patients' genetic profile. However, there is limited scientific evidence supporting its efficacy or guiding its implementation. The Precision Medicine in Mental Health (PRIME) Care study is a pragmatic randomized controlled trial evaluating the effectiveness of a specific commercially-available pharmacogenetic (PGx) test to inform antidepressant prescribing at 22 sites across the U.S. Simultaneous implementation science methods using the Consolidated Framework for Implementation Research (CFIR) are integrated throughout the trial to identify contextual factors likely to be important in future implementation of PGx. The goal of this study was to understand prov

SUBMITTER: Vest BM 

PROVIDER: S-EPMC7594429 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature